2006 IR News

RSS

IR News

11.22.2006 Santen Global Portal Open

11.13.2006 Santen to Launch Sante AL Cool II

11.01.2006 Santen Announces Financial Results for the First Six Months ended September 30, 2006 [PDF:16KB]

09.25.2006 Santen to Launch OTC Eye Drops Sante Medical 10

08.01.2006 Santen Files for Manufacturing and Marketing Approval for its Glaucoma and Ocular Hypertension Drug Candidate DE-085 (INN: Tafluprost)

07.31.2006 Santen Announces Financial Result for the First Quarter ended June 30, 2006

07.25.2006 2006-2010 Medium-term Management Plan

07.04.2006 Notice on the Exercise Price of Stock Options (Stock Acquisition Rights)

06.27.2006 Notice on the Allotment of Stock Options (Stock Acquisition Rights)

05.23.2006 Change in Issuance of Right to Subscribe for New Shares as Stock Options for Directors

05.09.2006 Santen to Issue Stock Acquisition Rights to the Directors

05.09.2006 Santen Announces Financial Results for the Year ended March 31,2006[PDF:16KB]

04.14.2006 Announcement of Change of Representative Directors

03.28.2006 Agreement Concerning Microsphere-based Platform Development and License

03.22.2006 Licensing Agreement on PDE4 Inhibitor ONO-6126

03.22.2006 Agreement Concerning Joint Research of Ophthalmic drug

02.28.2006 Santen Announces Preliminary Results of Overseas Clinical Trials of Two Glaucoma Drug Candidates

02.14.2006 Santen Announces Financial Result for the Third Quarter of Fiscal Year 2005 (Nine months ended December 31, 2005)

01.31.2006 Santen Announces Financial Result for the Third Quarter of Fiscal Year 2005( Nine months ended December 31, 2005)

01.23.2006 Santen Launches PAPILOCK Mini Ophthalmic Solution 0.1%

Official SNS

YouTube

Copyright © 2023 Santen Pharmaceutical Co., Ltd.
All Rights Reserved